Literature DB >> 32385107

Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.

Naoto Hori1, Kazuyuki Okada1, Yuki Takakura1, Hiroyuki Takano2, Naoto Yamaguchi1, Noritaka Yamaguchi3.   

Abstract

Vestigial-like 3 (VGLL3) is a member of the VGLL family, whose members serve as cofactors for TEA domain-containing transcription factors (TEADs). TEADs promote tissue and tumor development together with the cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Although VGLL3 is involved in tumor cell proliferation, its relationship with TEADs and YAP/TAZ remains largely unknown. To close this research gap, here we established tumor cells stably expressing VGLL3 and found that they exhibit enhanced proliferation. Notably, YAP and TAZ were inactivated in the VGLL3-expressing cells, coinciding with activation of the Hippo pathway, which suppresses YAP/TAZ activities. VGLL3 in combination with TEADs promoted expression of the Hippo pathway components large tumor suppressor kinase (LATS2) and angiomotin-like 2 (AMOTL2). VGLL3 was highly expressed in malignant breast tumor cells and osteosarcoma cells, and VGLL3 knockdown increased nuclear localization of YAP and TAZ. Knockdown of LATS2 or AMOTL2, as well as VGLL3 knockdown, repressed proliferation of breast tumor cells. Together, these results suggest that VGLL3 together with TEADs promotes cell proliferation by activating the Hippo pathway through LATS2 and AMOTL2, leading to YAP/TAZ inactivation.
© 2020 Hori et al.

Entities:  

Keywords:  Hippo pathway; TEA domain–containing transcription factor (TEAD); Yes-associated protein (YAP); cancer; cell proliferation; cell signaling; transcription coactivator; transcriptional coactivator with PDZ-binding motif (TAZ); vestigial-like 3 (VGLL3)

Mesh:

Substances:

Year:  2020        PMID: 32385107      PMCID: PMC7324512          DOI: 10.1074/jbc.RA120.012781

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  From vestigial to vestigial-like: the Drosophila gene that has taken wing.

Authors:  Emilie Simon; Corinne Faucheux; Alain Zider; Nadine Thézé; Pierre Thiébaud
Journal:  Dev Genes Evol       Date:  2016-04-26       Impact factor: 0.900

2.  Role of YAP/TAZ in mechanotransduction.

Authors:  Sirio Dupont; Leonardo Morsut; Mariaceleste Aragona; Elena Enzo; Stefano Giulitti; Michelangelo Cordenonsi; Francesca Zanconato; Jimmy Le Digabel; Mattia Forcato; Silvio Bicciato; Nicola Elvassore; Stefano Piccolo
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

3.  YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas.

Authors:  Zofia Hélias-Rodzewicz; Gaëlle Pérot; Frédéric Chibon; Céline Ferreira; Pauline Lagarde; Philippe Terrier; Jean-Michel Coindre; Alain Aurias
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

4.  The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.

Authors:  William M Mahoney; Jeong-Ho Hong; Michael B Yaffe; Iain K G Farrance
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

5.  A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer.

Authors:  Shi Jiao; Huizhen Wang; Zhubing Shi; Aimei Dong; Wenjing Zhang; Xiaomin Song; Feng He; Yicui Wang; Zhenzhen Zhang; Wenjia Wang; Xin Wang; Tong Guo; Peixue Li; Yun Zhao; Hongbin Ji; Lei Zhang; Zhaocai Zhou
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

6.  Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

Authors:  Yawei Hao; Alex Chun; Kevin Cheung; Babak Rashidi; Xiaolong Yang
Journal:  J Biol Chem       Date:  2007-12-24       Impact factor: 5.157

7.  TEAD mediates YAP-dependent gene induction and growth control.

Authors:  Bin Zhao; Xin Ye; Jindan Yu; Li Li; Weiquan Li; Siming Li; Jianjun Yu; Jiandie D Lin; Cun-Yu Wang; Arul M Chinnaiyan; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2008-06-25       Impact factor: 11.361

8.  Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.

Authors:  Changzhao Li; Ritesh K Srivastava; Craig A Elmets; Farrukh Afaq; Mohammad Athar
Journal:  Biochem Biophys Res Commun       Date:  2013-08-11       Impact factor: 3.575

9.  VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.

Authors:  Nicolas Figeac; Abdalla D Mohamed; Congshan Sun; Martin Schönfelder; David Matallanas; Amaya Garcia-Munoz; Edoardo Missiaglia; Elaina Collie-Duguid; Vanessa De Mello; Ajaybabu V Pobbati; Johanna Pruller; Oihane Jaka; Stephen D R Harridge; Wanjin Hong; Janet Shipley; Neil Vargesson; Peter S Zammit; Henning Wackerhage
Journal:  J Cell Sci       Date:  2019-07-05       Impact factor: 5.285

10.  Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer.

Authors:  Li-Hua Zhang; Zhuo Wang; Long-Hai Li; Yan-Kui Liu; Lin-Fang Jin; Xiao-Wei Qi; Chun Zhang; Teng Wang; Dong Hua
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

View more
  6 in total

1.  Vestigial-Like 3 Plays an Important Role in Osteoblast Differentiation by Regulating the Expression of Osteogenic Transcription Factors and BMP Signaling.

Authors:  Haoze Yuan; Mika Ikegame; Yoko Fukuhara; Fumiko Takemoto; Yaqiong Yu; Jumpei Teramachi; Yao Weng; Jiajie Guo; Daisuke Yamada; Takeshi Takarada; Ying Li; Hirohiko Okamura; Bin Zhang
Journal:  Calcif Tissue Int       Date:  2022-06-24       Impact factor: 4.000

2.  A novel tumor suppressor role of myosin light chain kinase splice variants through downregulation of the TEAD4/CD44 axis.

Authors:  Yen-Ju Huang; Tsung-Chun Lee; Yu-Chen Pai; Been-Ren Lin; Jerrold R Turner; Linda Chia-Hui Yu
Journal:  Carcinogenesis       Date:  2021-07-16       Impact factor: 4.944

3.  Skeletal muscle phenotyping of Hippo gene-mutated mice reveals that Lats1 deletion increases the percentage of type I muscle fibers.

Authors:  Fakhreddin Yaghoob Nezhad; Annett Riermeier; Martin Schönfelder; Lore Becker; Martin Hrabĕ de Angelis; Henning Wackerhage
Journal:  Transgenic Res       Date:  2022-01-05       Impact factor: 2.788

4.  Vestigial-like family member 3 stimulates cell motility by inducing high-mobility group AT-hook 2 expression in cancer cells.

Authors:  Naoto Hori; Yuki Takakura; Ayumi Sugino; Shuto Iwasawa; Kota Nomizo; Naoto Yamaguchi; Hiroyuki Takano; Noritaka Yamaguchi
Journal:  J Cell Mol Med       Date:  2022-04-02       Impact factor: 5.295

5.  Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway.

Authors:  Yu Du; Ran Cui; Na Tian; Miao Chen; Xian-Long Zhang; Sheng-Ming Dai
Journal:  Arthritis Res Ther       Date:  2022-08-08       Impact factor: 5.606

6.  Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma.

Authors:  Almudena Espín-Pérez; Kevin Brennan; Asiri Saumya Ediriwickrema; Olivier Gevaert; Izidore S Lossos; Andrew J Gentles
Journal:  NPJ Precis Oncol       Date:  2022-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.